Product Information
PHENOBARBITAL 16.2 MG TABLET is a generic product labeled by e5 Pharma, LLC, priced at $0.0559 per EA under NDC 13517062510. Its NADAC has been published 191 times since Feb 8, 2023.
Strength
16.2 mg/1
Manufacturer
e5 Pharma, LLCNDC
13517062510
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PHENOBARBITALApproval Type
Unapproved
On Market Since
11/30/2022
Price Statistics
The NADAC for PHENOBARBITAL 16.2 MG TABLET has been published 191 times since Feb 8, 2023, and over the history we have for it it has declined 65.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0559 per EA |
|---|---|
| All-time high | $0.2697 (Aug 16, 2023) |
| All-time low | $0.0483 (Jun 17, 2026) |
| 52-week high | $0.0692 |
| 52-week low | $0.0483 |
| Median price | $0.1048 |
| Average price | $0.1147 |
| Largest weekly change | +149.4% (Jun 19, 2024) |
| Weeks tracked | 191 |
| Tracking since | Feb 8, 2023 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 12% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
e5 Pharma, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
phenobarbital market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PHENOBARBITAL 16.2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PHENOBARBITAL 16.2 MG TABLET, manufactured by e5 Pharma, LLC, is $0.0559 per EA (NDC 13517062510), effective Sep 30, 2026.
How has the price of PHENOBARBITAL 16.2 MG TABLET changed over time?
Over the history we have for it, the NADAC for PHENOBARBITAL 16.2 MG TABLET has declined 65.2%. It has been tracked across 191 weekly CMS publications since Feb 8, 2023.
What are the highest and lowest recorded NADAC prices for PHENOBARBITAL 16.2 MG TABLET?
Since Feb 8, 2023, the NADAC for PHENOBARBITAL 16.2 MG TABLET has ranged from a low of $0.0483 (Jun 17, 2026) to a high of $0.2697 (Aug 16, 2023), with a median of $0.1048 per EA.
Are there cheaper alternatives to PHENOBARBITAL 16.2 MG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PHENOBARBITAL 16.2 MG TABLET, is $0.0495 per EA — about 12% below PHENOBARBITAL 16.2 MG TABLET.
Who manufactures PHENOBARBITAL 16.2 MG TABLET?
PHENOBARBITAL 16.2 MG TABLET (NDC 13517062510) is labeled by e5 Pharma, LLC, and CMS classifies it as a generic product.